Clinical Pharmacology
•
Program Development Strategies (Defining and outlining studies needed for Regulatory Filings)
•
Protocol Development for Phase 1-4 studies
•
PK\PD data analysis and interpretation
•
Report Writing
•
Investigator Brochures
•
Preparation of Clinical Pharmacology Sections for Regulatory submissions (INDs, NDAs, BLAs, Labeling)
•
Regulatory Interactions (US, Europe, Japan)
•
Abstracts, Manuscripts and Posters
•
Due Diligence Reviews